Comparison of LC-MS and LC-DAD Methods of Detecting Abused Piperazine Designer Drugs

Recreational use of piperazine designer drugs is a serious threat to human health. These compounds act on the body in a similar fashion to illegal drugs. They induce psychostimulatory effects as well as visual and auditory hallucinations to varying degrees. In many cases of poisoning and deaths, the...

Full description

Bibliographic Details
Main Authors: Anna Welz, Marcin Koba, Piotr Kośliński, Joanna Siódmiak
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/7/1758
_version_ 1797438878217404416
author Anna Welz
Marcin Koba
Piotr Kośliński
Joanna Siódmiak
author_facet Anna Welz
Marcin Koba
Piotr Kośliński
Joanna Siódmiak
author_sort Anna Welz
collection DOAJ
description Recreational use of piperazine designer drugs is a serious threat to human health. These compounds act on the body in a similar fashion to illegal drugs. They induce psychostimulatory effects as well as visual and auditory hallucinations to varying degrees. In many cases of poisoning and deaths, the presence of two or even several psychoactive substances have been demonstrated. Piperazine derivatives are often found in such mixtures and pose a great analytical problem during their identification. Additionally, some piperazine derivatives can be detected in biological material as a result of metabolic changes to related drugs. Therefore, it is necessary to correctly identify these compounds and ensure repeatability of determinations. This article presents a comparison of the methods used to detect abused piperazine designer drugs using liquid chromatography in combination with a diode-array detector (LC-DAD) or mass spectrometer (LC-MS). Each of methods can be used independently for determinations, obtaining reliable results in a short time of analysis. These methods can also complement each other, providing qualitative and quantitative confirmation of results. The proposed methods provide analytical confirmation of poisoning and may be helpful in toxicological diagnostics.
first_indexed 2024-03-09T11:44:39Z
format Article
id doaj.art-98af2ca555f245c993f6da043427b4bb
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T11:44:39Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-98af2ca555f245c993f6da043427b4bb2023-11-30T23:26:27ZengMDPI AGJournal of Clinical Medicine2077-03832022-03-01117175810.3390/jcm11071758Comparison of LC-MS and LC-DAD Methods of Detecting Abused Piperazine Designer DrugsAnna Welz0Marcin Koba1Piotr Kośliński2Joanna Siódmiak3Department of Toxicology and Bromatology, Faculty of Pharmacy, Collegium Medicum Nicolaus Copernicus University, 85-089 Bydgoszcz, PolandDepartment of Toxicology and Bromatology, Faculty of Pharmacy, Collegium Medicum Nicolaus Copernicus University, 85-089 Bydgoszcz, PolandDepartment of Toxicology and Bromatology, Faculty of Pharmacy, Collegium Medicum Nicolaus Copernicus University, 85-089 Bydgoszcz, PolandDepartment of Laboratory Diagnostics, Faculty of Pharmacy, Collegium Medicum Nicolaus Copernicus University, 85-094 Bydgoszcz, PolandRecreational use of piperazine designer drugs is a serious threat to human health. These compounds act on the body in a similar fashion to illegal drugs. They induce psychostimulatory effects as well as visual and auditory hallucinations to varying degrees. In many cases of poisoning and deaths, the presence of two or even several psychoactive substances have been demonstrated. Piperazine derivatives are often found in such mixtures and pose a great analytical problem during their identification. Additionally, some piperazine derivatives can be detected in biological material as a result of metabolic changes to related drugs. Therefore, it is necessary to correctly identify these compounds and ensure repeatability of determinations. This article presents a comparison of the methods used to detect abused piperazine designer drugs using liquid chromatography in combination with a diode-array detector (LC-DAD) or mass spectrometer (LC-MS). Each of methods can be used independently for determinations, obtaining reliable results in a short time of analysis. These methods can also complement each other, providing qualitative and quantitative confirmation of results. The proposed methods provide analytical confirmation of poisoning and may be helpful in toxicological diagnostics.https://www.mdpi.com/2077-0383/11/7/1758piperazine designer drugsbenzylpiperazine derivativesphenylpiperazine derivativesLC-MSLC-DADdrugs of abuse
spellingShingle Anna Welz
Marcin Koba
Piotr Kośliński
Joanna Siódmiak
Comparison of LC-MS and LC-DAD Methods of Detecting Abused Piperazine Designer Drugs
Journal of Clinical Medicine
piperazine designer drugs
benzylpiperazine derivatives
phenylpiperazine derivatives
LC-MS
LC-DAD
drugs of abuse
title Comparison of LC-MS and LC-DAD Methods of Detecting Abused Piperazine Designer Drugs
title_full Comparison of LC-MS and LC-DAD Methods of Detecting Abused Piperazine Designer Drugs
title_fullStr Comparison of LC-MS and LC-DAD Methods of Detecting Abused Piperazine Designer Drugs
title_full_unstemmed Comparison of LC-MS and LC-DAD Methods of Detecting Abused Piperazine Designer Drugs
title_short Comparison of LC-MS and LC-DAD Methods of Detecting Abused Piperazine Designer Drugs
title_sort comparison of lc ms and lc dad methods of detecting abused piperazine designer drugs
topic piperazine designer drugs
benzylpiperazine derivatives
phenylpiperazine derivatives
LC-MS
LC-DAD
drugs of abuse
url https://www.mdpi.com/2077-0383/11/7/1758
work_keys_str_mv AT annawelz comparisonoflcmsandlcdadmethodsofdetectingabusedpiperazinedesignerdrugs
AT marcinkoba comparisonoflcmsandlcdadmethodsofdetectingabusedpiperazinedesignerdrugs
AT piotrkoslinski comparisonoflcmsandlcdadmethodsofdetectingabusedpiperazinedesignerdrugs
AT joannasiodmiak comparisonoflcmsandlcdadmethodsofdetectingabusedpiperazinedesignerdrugs